A detailed history of Advisors Asset Management, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 9,722 shares of JAZZ stock, worth $984,546. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,722
Previous 8,903 9.2%
Holding current value
$984,546
Previous $1.1 Million 6.85%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$115.19 - $132.77 $94,340 - $108,738
819 Added 9.2%
9,722 $1.17 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $53,359 - $63,512
-467 Reduced 4.98%
8,903 $1.1 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $262,150 - $314,922
-2,140 Reduced 18.59%
9,370 $1.16 Million
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $163,455 - $195,773
1,220 Added 11.86%
11,510 $1.68 Million
Q3 2022

Nov 08, 2022

SELL
$126.59 - $161.18 $34,812 - $44,324
-275 Reduced 4.78%
5,478 $730,000
Q2 2022

Aug 08, 2022

BUY
$141.59 - $168.66 $46,441 - $55,320
328 Added 6.05%
5,753 $898,000
Q1 2022

May 17, 2022

BUY
$129.64 - $160.7 $122,380 - $151,700
944 Added 21.07%
5,425 $845,000
Q4 2021

Feb 15, 2022

BUY
$119.87 - $145.67 $172,492 - $209,619
1,439 Added 47.3%
4,481 $571,000
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $285,323 - $409,864
2,218 Added 269.17%
3,042 $396,000
Q2 2021

Jul 30, 2021

BUY
$160.2 - $186.42 $94,197 - $109,614
588 Added 249.15%
824 $146,000
Q1 2021

May 07, 2021

SELL
$150.19 - $173.5 $1,051 - $1,214
-7 Reduced 2.88%
236 $39,000
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $2,251 - $2,640
-16 Reduced 6.18%
243 $40,000
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $210 - $288
-2 Reduced 0.77%
259 $37,000
Q2 2020

Aug 12, 2020

SELL
$95.68 - $121.88 $185,714 - $236,569
-1,941 Reduced 88.15%
261 $29,000
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $206,101 - $358,786
-2,349 Reduced 51.62%
2,202 $220,000
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $57,766 - $75,481
-491 Reduced 9.74%
4,551 $679,000
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $357,013 - $408,520
-2,852 Reduced 36.13%
5,042 $646,000
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $259,135 - $298,206
-2,064 Reduced 20.73%
7,894 $1.13 Million
Q1 2019

May 15, 2019

SELL
$121.81 - $142.95 $643,887 - $755,633
-5,286 Reduced 34.68%
9,958 $1.42 Million
Q4 2018

Jan 31, 2019

SELL
$115.94 - $166.74 $66,897 - $96,208
-577 Reduced 3.65%
15,244 $1.89 Million
Q3 2018

Nov 15, 2018

BUY
$161.01 - $180.57 $240,870 - $270,132
1,496 Added 10.44%
15,821 $2.66 Million
Q2 2018

Aug 15, 2018

SELL
$146.33 - $183.18 $289,879 - $362,879
-1,981 Reduced 12.15%
14,325 $2.47 Million
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $68,608 - $79,522
-506 Reduced 3.01%
16,306 $2.36 Million
Q4 2017

Feb 13, 2018

BUY
$131.06 - $150.39 $63,039 - $72,337
481 Added 2.95%
16,812 $2.26 Million
Q3 2017

Nov 07, 2017

BUY
$142.62 - $155.6 $2.33 Million - $2.54 Million
16,331
16,331 $2.39 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.35B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.